A carregar...
Publicação
Estudo de viabilidade económica de novos produtos lançados na Indústria Farmacêutica
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 671.56 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Nas últimas duas décadas, o Brasil tem estado num ciclo de estabilidade política e económica que tem gerado um efeito positivo no desenvolvimento da economia nacional.
Nos últimos 15 anos tem havido um esforço, no Brasil, no sentido de expansão e modernização da Indústria Farmacêutica. Assim sendo, a Indústria Farmacêutica Brasileira é a maior e mais desenvolvida na América Latina e, atualmente, o Brasil encontra-se no sexto lugar no ranking mundial da Indústria Farmacêutica, com perspetivas futuras de crescimento otimistas.
No Brasil, estima-se que mais de 35 milhões de pessoas têm algum tipo de deficiência visual, de acordo com os últimos censos demográficos realizados.
Como tal, é possível afirmar-se que o Mercado Oftalmológico Brasileiro está em crescimento devido, na sua maioria, a duas razões principais: um maior número de doentes a necessitar de tratamentos e o lançamento de uma grande quantidade de produtos inovadores neste setor, uma vez que as empresas da Indústria Farmacêutica estão a investir mais em R&D.
Para analisar o contexto atual e inferir as necessidades futuras do Mercado Oftalmológico Brasileiro recorreu-se a uma metodologia dupla. Esta metodologia conjugou fontes secundárias bibliográficas e sindicalizadas com informação de caráter primário obtida a partir de in-depth interviews realizadas a Oftalmologistas KOL no mercado em estudo.
Na generalidade, os produtos comercializados no Mercado Oftalmológico do Brasil têm uma boa qualidade, porém, este é um mercado que está a crescer a um ritmo positivo e há sempre necessidade de novos produtos inovadores.
In the past two decades, Brazil has been in a cycle of political and economic stability that has been generating a positive effect on the development of the national economy. In the last 15 years, there has been an effort, in Brazil, towards the expansion and modernization of the Pharmaceutical Industry. Therefore, the Brazilian Pharmaceutical Industry is the largest and most developed in Latin America and, currently, Brazil occupies the sixth place in the ranking of the Pharmaceutical Industry worldwide, with optimistic future growth prospects. Currently, in Brazil, it is estimated that more than 35 million people have some type of visual impairment, according to the latest demographic censuses carried out. As such, it is possible to state that the Brazilian Ophthalmological Market is growing, mostly due to two main reasons: a greater number of patients in need of treatment and the launch of a large number of innovative products in this sector, since the companies of the Pharmaceutical Industry are investing more in R&D. To analyze the actual context and to understand the future needs of the Brazilian Ophthalmological Market, was used a double methodology that combined sindicalized secondary data with primary data obtained from in-depth interviews conducted with KOL Ophthalmologists, in the market in study. In general, the products available in the Ophthalmological Market in Brazil have a good quality, however, this is a market that is growing at a positive pace and there is always need for new innovative products.
In the past two decades, Brazil has been in a cycle of political and economic stability that has been generating a positive effect on the development of the national economy. In the last 15 years, there has been an effort, in Brazil, towards the expansion and modernization of the Pharmaceutical Industry. Therefore, the Brazilian Pharmaceutical Industry is the largest and most developed in Latin America and, currently, Brazil occupies the sixth place in the ranking of the Pharmaceutical Industry worldwide, with optimistic future growth prospects. Currently, in Brazil, it is estimated that more than 35 million people have some type of visual impairment, according to the latest demographic censuses carried out. As such, it is possible to state that the Brazilian Ophthalmological Market is growing, mostly due to two main reasons: a greater number of patients in need of treatment and the launch of a large number of innovative products in this sector, since the companies of the Pharmaceutical Industry are investing more in R&D. To analyze the actual context and to understand the future needs of the Brazilian Ophthalmological Market, was used a double methodology that combined sindicalized secondary data with primary data obtained from in-depth interviews conducted with KOL Ophthalmologists, in the market in study. In general, the products available in the Ophthalmological Market in Brazil have a good quality, however, this is a market that is growing at a positive pace and there is always need for new innovative products.
Descrição
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, 2020, Universidade de Lisboa, Faculdade de Farmácia.
Palavras-chave
Brasil Indústria farmacêutica Oftalmologia Análise de mercado Mestrado integrado - 2020